Heart Failure Congestive
220
5
7
167
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
40 trials with published results (18%)
Research Maturity
167 completed trials (76% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.1%
20 terminated out of 220 trials
89.3%
+2.8% vs benchmark
29%
63 trials in Phase 3/4
24%
40 of 167 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 167 completed trials
Clinical Trials (220)
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements
Cardiovascular Health Study (CHS)
VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Registry of Patients With CardioMEMS
Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.
X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure
MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure
Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)
My Recordable On-Demand Audio Discharge Instructions
COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic Diseases
Facilitating Communication Study
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance
Multiple Cardiac Sensors for the Management of Heart Failure
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
ANTHEM-HFrEF Pivotal Study